SK53194A3 - Benzofuranyl and benzothiophenyl-alkanecarboxylic acid derivatives, method of their preparation and their using as medicaments - Google Patents

Benzofuranyl and benzothiophenyl-alkanecarboxylic acid derivatives, method of their preparation and their using as medicaments Download PDF

Info

Publication number
SK53194A3
SK53194A3 SK531-94A SK53194A SK53194A3 SK 53194 A3 SK53194 A3 SK 53194A3 SK 53194 A SK53194 A SK 53194A SK 53194 A3 SK53194 A3 SK 53194A3
Authority
SK
Slovakia
Prior art keywords
group
carbon atoms
straight
formula
branched chain
Prior art date
Application number
SK531-94A
Other languages
English (en)
Slovak (sk)
Inventor
Rudiger Fischer
Gabriele Braunlich
Klaus-Helmut Mohrs
Rudolf Hanko
John-E Butler-Ransohoff
Mazen Es-Sayed
Graham Sturton
Steve Tudhope
Trevor Abram
Wendy J Mcdonald-Gibson
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SK53194A3 publication Critical patent/SK53194A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK531-94A 1993-05-06 1994-05-06 Benzofuranyl and benzothiophenyl-alkanecarboxylic acid derivatives, method of their preparation and their using as medicaments SK53194A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939309324A GB9309324D0 (en) 1993-05-06 1993-05-06 Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives

Publications (1)

Publication Number Publication Date
SK53194A3 true SK53194A3 (en) 1995-02-08

Family

ID=10735023

Family Applications (1)

Application Number Title Priority Date Filing Date
SK531-94A SK53194A3 (en) 1993-05-06 1994-05-06 Benzofuranyl and benzothiophenyl-alkanecarboxylic acid derivatives, method of their preparation and their using as medicaments

Country Status (21)

Country Link
US (1) US5504213A (fr)
EP (1) EP0623607B1 (fr)
JP (1) JP3452088B2 (fr)
CN (1) CN1097749A (fr)
AT (1) ATE168373T1 (fr)
AU (1) AU678814B2 (fr)
CA (1) CA2122788A1 (fr)
CZ (1) CZ112994A3 (fr)
DE (1) DE69411625T2 (fr)
DK (1) DK0623607T3 (fr)
ES (1) ES2118283T3 (fr)
FI (1) FI942049A (fr)
GB (1) GB9309324D0 (fr)
GR (1) GR3027787T3 (fr)
HU (1) HUT67847A (fr)
IL (1) IL109526A0 (fr)
NO (1) NO941662L (fr)
NZ (1) NZ260445A (fr)
RU (1) RU2125564C1 (fr)
SK (1) SK53194A3 (fr)
ZA (1) ZA943100B (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721233A (en) * 1992-04-06 1998-02-24 Merrell Pharmaceuticals Inc. Derivatives of 2,3-dihydro benzofuranols
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
GB9410877D0 (en) * 1994-05-31 1994-07-20 Bayer Ag Heterocyclycarbonyl substituted benzoduranyl-and-thiophenyl-alkanecarboxyclic acid derivatives
HRP950288A2 (en) * 1994-05-31 1997-08-31 Bayer Ag Oxalylamino-benzofuran- and benzothienyl-derivatives
ATE175667T1 (de) * 1994-05-31 1999-01-15 Bayer Ag Aminobenzofuryl- und -thienylderivate
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
EP0751126A4 (fr) * 1995-01-06 1998-05-13 Toray Industries Derive heterocyclique benzocondense et son utilisation
GB9504460D0 (en) * 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
CZ371998A3 (cs) * 1996-05-20 1999-03-17 Darwin Discovery Limited Benzofuranové karboxamidy a jejich terapeutické použití
GB9614718D0 (en) 1996-07-12 1996-09-04 Bayer Ag 3-ureido-pyridofurans and -pyridothiophenes
DE19642451A1 (de) * 1996-10-15 1998-04-16 Merck Patent Gmbh Aminothiophencarbonsäureamide
DE19706396A1 (de) * 1996-12-09 1998-06-10 Bayer Ag Verfahren zur Herstellung von 3-(l-Hydroxiphenyl-l-alkoximinomethyl)dioxazinen
GB2350111A (en) * 1999-05-17 2000-11-22 Bayer Ag Oligohydroxyl substituted 3-urea-benzofuran and pyridofuran derivatives
GB2350109A (en) 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active benzofuranyl sulfonates
KR100701904B1 (ko) 1999-08-21 2007-04-02 알타나 파마 아게 Pde 억제제 및 베타 2 아드레날린수용체 작동제의상승적 조합
KR100854424B1 (ko) 2001-01-29 2008-08-27 3-디멘져널 파마슈티칼즈 인코오포레이티드 치환된 인돌 및 인테그린 길항제로서의 이들의 용도
US6872730B2 (en) 2001-04-27 2005-03-29 3-Dimensional Pharmaceuticals, Inc. Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
CA2447618A1 (fr) 2001-05-23 2002-11-28 Tanabe Seiyaku Co., Ltd. Composition pour le traitement regeneratif de la maladie du cartilage
CN1520313A (zh) 2001-05-23 2004-08-11 ������ҩ��ʽ���� 一种加速骨折愈合的组合物
US7144885B2 (en) 2002-02-22 2006-12-05 Bayer Pharmaceuticals Corporation Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
US7351735B2 (en) * 2002-02-22 2008-04-01 Bayer Pharmaceuticals Corporation Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
KR20050115331A (ko) 2003-04-01 2005-12-07 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. 불임증 포스포디에스터라제의 억제제
EP1627873A4 (fr) * 2003-05-29 2007-12-05 New Ind Res Organization Compose a base de benzofurane et composition medicinale contenant ce compose
JP2005008631A (ja) * 2003-05-29 2005-01-13 New Industry Research Organization ベンゾフラン化合物、およびそれを含有してなる医薬組成物
US7576122B2 (en) * 2003-09-02 2009-08-18 Merck & Co. Inc. Ophthalmic compositions for treating ocular hypertension
AR051780A1 (es) * 2004-11-29 2007-02-07 Japan Tobacco Inc Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
ME00535B (me) * 2006-06-27 2011-10-10 Takeda Pharmaceuticals Co Fuzionisana ciklična jedinjenja
WO2008025509A1 (fr) * 2006-09-01 2008-03-06 Bayer Schering Pharma Aktiengesellschaft Dérivés de benzofurane et de benzothiophène utiles dans le traitement de cancers du système nerveux central
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
AU2008261102B2 (en) 2007-06-04 2013-11-28 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2930674A1 (fr) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonistes de guanylate cyclase utile dans le traitement de troubles gastro-intestinaux, d'une inflammation, d'un cancer et d'autres troubles
JP2011528375A (ja) 2008-07-16 2011-11-17 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN108676076A (zh) 2011-03-01 2018-10-19 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
EP3718557A3 (fr) 2013-02-25 2020-10-21 Bausch Health Ireland Limited Agoniste du récepteur de la guanylate cyclase sp-333 à utiliser lors du nettoyage du côlon
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
CA2905438A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonistes de la guanylate cyclase et leurs utilisations
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法
NZ717739A (en) 2013-08-09 2023-12-22 Ardelyx Inc Compounds and methods for inhibiting phosphate transport
WO2015029062A1 (fr) 2013-08-25 2015-03-05 Council Of Scientific And Industrial Rsearch Procédé de préparation de composés d'aroylbenzofuranne anti-inflammatoires
JP6449915B2 (ja) * 2014-02-25 2019-01-09 エコラボ ユーエスエー インコーポレイティド 衛生洗剤
CN105254611B (zh) * 2015-11-09 2017-10-31 江西仁明医药化工有限公司 苯并噻吩‑2‑羧酸的制备方法
CN107935972B (zh) * 2017-11-14 2020-06-02 沈阳药科大学 5-[2-羟基-3-(异丙胺基)丙氧基]苯并呋喃类衍生物及其应用
CN107857748B (zh) * 2017-11-14 2020-06-02 沈阳药科大学 5-[2-羟基-3-(烷胺基)丙氧基]苯并呋喃类化合物及其应用
CN107827849B (zh) * 2017-11-14 2020-06-02 沈阳药科大学 6-[2-羟基-3-(烷胺基)丙氧基]苯并呋喃类化合物及其应用
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport
CN110938035B (zh) * 2019-10-28 2022-07-01 广西师范大学 9-苯磺酸-10-咪蒽腙及其合成方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019955A1 (fr) * 1979-05-16 1980-12-10 Shell Internationale Researchmaatschappij B.V. Dérivés d'acide benzofuranne-carboxylique, leur préparation et leur utilisation dans des compositions inhibant la lipogenèse
EP0146243A1 (fr) * 1983-10-31 1985-06-26 Merck Frosst Canada Inc. Inhibiteurs de la lipoxygénase
US4663347A (en) * 1983-10-31 1987-05-05 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis
US4482772A (en) * 1983-11-03 1984-11-13 Mobil Oil Corporation Multistage process for converting oxygenates to hydrocarbons

Also Published As

Publication number Publication date
ATE168373T1 (de) 1998-08-15
CN1097749A (zh) 1995-01-25
JP3452088B2 (ja) 2003-09-29
DE69411625T2 (de) 1998-11-05
ES2118283T3 (es) 1998-09-16
JPH06329652A (ja) 1994-11-29
CZ112994A3 (en) 1994-11-16
HU9401415D0 (en) 1994-08-29
DE69411625D1 (de) 1998-08-20
RU94015838A (ru) 1997-02-20
NO941662L (no) 1994-11-07
FI942049A0 (fi) 1994-05-04
NO941662D0 (no) 1994-05-05
EP0623607A1 (fr) 1994-11-09
EP0623607B1 (fr) 1998-07-15
IL109526A0 (en) 1994-08-26
AU6055894A (en) 1994-11-10
GR3027787T3 (en) 1998-11-30
DK0623607T3 (da) 1999-04-19
FI942049A (fi) 1994-11-07
HUT67847A (en) 1995-05-29
ZA943100B (en) 1995-01-09
GB9309324D0 (en) 1993-06-16
RU2125564C1 (ru) 1999-01-27
NZ260445A (en) 1995-08-28
CA2122788A1 (fr) 1994-11-07
US5504213A (en) 1996-04-02
AU678814B2 (en) 1997-06-12

Similar Documents

Publication Publication Date Title
SK53194A3 (en) Benzofuranyl and benzothiophenyl-alkanecarboxylic acid derivatives, method of their preparation and their using as medicaments
EP0685475B1 (fr) Dérivés de aminobenzofuryle et -thienyle
US6169092B1 (en) 3-Ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes
JP6215890B2 (ja) 縮合環類似体の抗線維症剤
EP0685474B1 (fr) Dérivés de oxalylamino-benzofuranne et -benzothienyle
US5691359A (en) Heterocyclylcarbonyl substituted benzofuranyl- and -thiophenyl-alkanecarboxyclic acid derivatives
DK169890B1 (da) 3-Substitueret 2-carboxy-indolderivater, farmaceutisk præparat indeholdende forbindelserne, fremgangsmåde til fremstilling af forbindelserne samt anvendelse af forbindelserne til fremstilling af et lægemiddel
US5972936A (en) Benzofuran carboxamides and their therapeutic use
JP3204901B2 (ja) N−(3−ベンゾフラニル)ウレア−誘導体
US6353010B1 (en) Bicyclic aryl carboxamides and their therapeutic use
EP1263757B1 (fr) Benzthiazoles utilises comme inhibiteurs de tnf et de pde-iv
AU2005287589A1 (en) Novel pyrimidine derivatives and their use as PPAR-alpha modulators
JP2001505198A (ja) Pde阻害剤としての置換ジヒドロベンゾフラン
KR20050099525A (ko) 피롤로트리아진 키나제 억제제의 제조 방법
AU2003202488A1 (en) Coumarin derivatives, process for their production and use thereof
KR19990071894A (ko) 벤조퓨란 카르복사미드 및 술폰아미드
JPH05271214A (ja) ベンゾフラニル−およびチオフエニルメチルチオ−アルカンカルボン酸誘導体
CN101809017A (zh) 酞嗪酮衍生物
DE60307804T2 (de) Pyranon- und pyrandioninhibitoren der rna-abhängigen rna-polymerase des hepatitis-c-virus
JPS63295566A (ja) キノキサリノン誘導体
JPH0692402B2 (ja) 複素環式オキソフタラジニル酢酸類
CZ390392A3 (en) Benzofuranyl- and thiophenylmethylthio alkanecarboxylic acid derivatives, process of their preparation and use
RU2232761C2 (ru) Производные триазола амидного типа, фармацевтическая композиция на их основе и способ профилактики или лечения
KR20020081480A (ko) 항바이러스제로서의 4-히드록시신놀린-3-카르복시아미드
SK2112003A3 (en) Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same